We are live on ! Find out more
CP

Covenant Partners Portfolio holdings

AUM $342M
1-Year Est. Return 19.24%
This Fund
S&P 500
This Quarter Est. Return
+6.32%
1 Year Est. Return
+19.24%
3 Year Est. Return
+70.32%
5 Year Est. Return
+79.29%
10 Year Est. Return
–
AUM
$265M
AUM Growth
+$13.8M
Cap. Flow
-$371K
Cap. Flow %
-0.14%
Top 10 Hldgs %
49.35%
Holding
208
New
7
Increased
11
Reduced
28
Closed
7

Top Buys

Rank Stock Value
1
EFV icon
iShares MSCI EAFE Value ETF
EFV
+$930K
2
UL icon
Unilever
UL
+$381K
3
EFG icon
iShares MSCI EAFE Growth ETF
EFG
+$367K
4
DXCM icon
DexCom
DXCM
+$322K
5
FND icon
Floor & Decor
FND
+$290K

Top Sells

Rank Stock Value
1
TAK icon
Takeda Pharmaceutical
TAK
+$487K
2
VZ icon
Verizon
VZ
+$317K
3
SPLK
Splunk Inc
SPLK
+$314K
4
NVS icon
Novartis
NVS
+$292K
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$231K

Sector Composition

Rank Sector Weight
1 Technology 17.39%
2 Healthcare 8.06%
3 Financials 7.83%
4 Consumer Discretionary 6.21%
5 Industrials 6.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABT icon
51
Abbott
ABT
$180B
$1M 0.38%
8,633
– –
CSCO icon
52
Cisco
CSCO
$450B
$1M 0.38%
18,884
– –
LMT icon
53
Lockheed Martin
LMT
$134B
$996K 0.38%
2,632
– –
CRM icon
54
Salesforce
CRM
$134B
$959K 0.36%
3,928
-236
-6% -$54.4K
PM icon
55
Philip Morris
PM
$301B
$931K 0.35%
9,392
– –
ABB
56
DELISTED
ABB Ltd
ABB
$898K 0.34%
26,418
– –
MRK icon
57
Merck
MRK
$324B
$896K 0.34%
11,522
-2,970
-20% -$221K
PSX icon
58
Phillips 66
PSX
$82.9B
$885K 0.33%
10,312
– –
PLD icon
59
Prologis
PLD
$138B
$876K 0.33%
7,332
– –
UPS icon
60
United Parcel Service
UPS
$97.6B
$871K 0.33%
4,188
– –
AKAM icon
61
Akamai
AKAM
$16.8B
$868K 0.33%
7,447
– –
AJG icon
62
Arthur J. Gallagher & Co
AJG
$63.7B
$853K 0.32%
6,092
– –
HYG icon
63
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.3B
$853K 0.32%
9,687
– –
MO icon
64
Altria Group
MO
$122B
$853K 0.32%
17,892
– –
GNRC icon
65
Generac Holdings
GNRC
$11.9B
$848K 0.32%
2,042
– –
TMO icon
66
Thermo Fisher Scientific
TMO
$211B
$843K 0.32%
1,672
– –
AHCO icon
67
AdaptHealth
AHCO
$1.46B
$830K 0.31%
30,271
+3,351
+12% +$95.6K
RACE icon
68
Ferrari
RACE
$63.3B
$810K 0.31%
3,929
– –
SBUX icon
69
Starbucks
SBUX
$118B
$781K 0.29%
6,988
– –
PNFP icon
70
Pinnacle Financial Partners Inc
PNFP
$15.5B
$777K 0.29%
8,796
– –
NEE icon
71
NextEra Energy
NEE
$187B
$774K 0.29%
10,557
– –
QCOM icon
72
Qualcomm
QCOM
$176B
$737K 0.28%
5,153
– –
CVX icon
73
Chevron
CVX
$388B
$723K 0.27%
6,899
+363
+6% +$38.3K
PEP icon
74
PepsiCo
PEP
$186B
$722K 0.27%
4,875
-65
-1% -$9.47K
AMAT icon
75
Applied Materials
AMAT
$426B
$711K 0.27%
4,992
– –
1 2
3
4 5

Similar funds

SHFA
SS&H Financial Advisors Troy, Michigan $343M AUM 28.43% 1-Year Est. Return
YCG
Yeomans Consulting Group Marietta, Georgia $341M AUM 22.92% 1-Year Est. Return
TAM
Tucker Asset Management Littleton, Colorado $343M AUM 17.55% 1-Year Est. Return
LODC
Lanham O'Dell & Company Hurricane, West Virginia $347M AUM 20.92% 1-Year Est. Return
OFS
Oldfather Financial Services Kearney, Nebraska $336M AUM 15.03% 1-Year Est. Return
MWM
MGB Wealth Management Addison, Texas $350M AUM 42.75% 1-Year Est. Return
PPH
Pure Portfolios Holdings Lake Oswego, Oregon $332M AUM 20.54% 1-Year Est. Return
TPW
Transatlantique Private Wealth New York $319M AUM 22.93% 1-Year Est. Return

Covenant Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Covenant Partners held 208 positions worth $265M, up 5.5% from $251M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Covenant Partners's Q2 2021 filing shows 7 new, 11 increased, 28 reduced and 7 closed positions. Its largest new stake was Unilever: 5,724 shares worth $377K. The largest sale was Takeda Pharmaceutical, an estimated $487K.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

  • Covenant Partners's largest Q2 2021 buy was Unilever: 5,724 shares worth $377K.
  • Covenant Partners added most to iShares MSCI EAFE Value ETF in Q2 2021, an estimated $930K increase.
  • Covenant Partners's biggest Q2 2021 reduction was Takeda Pharmaceutical, cutting an estimated $487K.
  • Covenant Partners fully exited BioMarin Pharmaceuticals in Q2 2021, selling an estimated $231K.
  • Covenant Partners's ten largest holdings make up 49% of its $265M portfolio in Q2 2021.
  • Covenant Partners opened 7 new positions and closed 7 in Q2 2021.
  • Covenant Partners's portfolio value rose 5.5% quarter-over-quarter to $265M.

Based on Covenant Partners's 13F filing for Q2 2021, filed 2 Aug 2021.